Skip to content
Disclosery

ORBIMED ADVISORS LLC: URGN position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on URGN, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 676,187 URGN shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 676,187 shares
    Change vs previous 13F -199,300 shares

    0.47% of the 13F portfolio, value $24,883,682.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 875,487 shares
    Change vs previous 13F 0 shares

    0.34% of the 13F portfolio, value $15,741,256.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 875,487 shares
    Change vs previous 13F +186,487 shares

    0.42% of the 13F portfolio, value $20,503,906.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 689,000 shares
    Change vs previous 13F +210,600 shares

    0.33% of the 13F portfolio, value $13,745,550.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 478,400 shares
    Change vs previous 13F not available

    0.16% of the 13F portfolio, value $6,554,080.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).